Cargando…

1526. Oral Fosfomycin Use for Urinary Tract Infections and Its Clinical Impact on Hospital Stay

BACKGROUND: Oral fosfomycin is a treatment option for urinary tract infections (UTI) caused by multi-drug-resistant organisms (MDRO). The objective of the study was to describe the prescribing pattern of fosfomycin and determine its role in (1) preventing hospital admissions for patients seen in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mai, Christina, Donaghy, Henry, Doan, Thien-Ly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254172/ http://dx.doi.org/10.1093/ofid/ofy210.1355

Ejemplares similares

1526. Hospitalized Patients with HIV – Defining the Population and the Impact of Barriers to Care
por: Hatlen, Timothy, et al.
Publicado: (2023)

Oral and intravenous fosfomycin in complicated urinary tract infections
por: López-Montesinos, Inmaculada, et al.
Publicado: (2019)

657. Evaluating Clinical Outcomes of Bacteremic Patients Treated with AmpC-Inducing Versus -Stable Agents
por: Barsoum, Barbara, et al.
Publicado: (2022)

Oral and Intravenous Fosfomycin for the Treatment of Complicated Urinary Tract Infections
por: Zhanel, George G., et al.
Publicado: (2020)

2261. Oral Fosfomycin for Treatment of Urinary Tract Infections Due to Extended-Spectrum β-Lactamase and Carbapenem-Resistant Enterobacteriaceae
por: Hefler, Jade L, et al.
Publicado: (2019)

2294. Comparative Evaluation of Ertapenem and Clindamycin Plus Gentamicin for the Treatment of Postpartum Endometritis
por: Schweiger, Krislyn, et al.
Publicado: (2019)

1120. Descriptive Analysis of Monoclonal Antibody Administration for Pregnant Patients with SARS-CoV-2 Infection
por: Vikraman, Praveen Kumar, et al.
Publicado: (2022)

1617. Assessment of Bloodstream Infections in Patients with Intrapartum Fever
por: Kamel, Barbara, et al.
Publicado: (2023)

96. Assessing the Impact of the Meningitis/encephalitis Diagnostic Panel on Antimicrobial Stewardship
por: Garellek, Jonathan, et al.
Publicado: (2020)

Oral fosfomycin for treatment of urinary tract infection: a retrospective cohort study
por: Matthews, Philippa C., et al.
Publicado: (2016)

341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab
por: Barsoum, Barbara, et al.
Publicado: (2021)

1525. Evaluation of Clinical Outcomes With Fosfomycin for E. coli and Non-E. coli Enterobacteriaceae Urinary Tract Infections
por: Lee, Tiffany, et al.
Publicado: (2018)

103. Evaluating The Appropriateness of Vaccine Administration in Patients with Splenectomy
por: Barsoum, Barbara, et al.
Publicado: (2022)

Multiple-Dose Oral Fosfomycin for Treatment of Complicated Urinary Tract Infections in the Outpatient Setting
por: Derington, Catherine G, et al.
Publicado: (2020)

1417. Fosfomycin Use in the Treatment of Complicated Urinary Tract Infections at a Veterans Affairs Medical Center
por: Lee, Ryan, et al.
Publicado: (2021)

2420. A Real-World Perspective on the Efficacy of Fosfomycin for Treatment of Multidrug-Resistant Pathogens Causing Urinary Tract Infections
por: Babiker, Ahmed, et al.
Publicado: (2018)

2819. Clinical Outcomes of Fosfomycin Treatment in E. coli vs. Non-E. coli Enterobacterales Urinary Tract Infection
por: Traugott, Kristi, et al.
Publicado: (2023)

Fosfomycin for management of persistent female lower urinary tract infection
por: Joob, Beuy, et al.
Publicado: (2018)

Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales
por: Bouiller, Kévin, et al.
Publicado: (2022)

1690. Oral Fosfomycin for the Treatment of Bacterial Prostatitis
por: Kamath, Meghan, et al.
Publicado: (2020)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

2959. Urinary tract colonizing abilities of fosfomycin (FOF) non-susceptible Klebsiella pneumoniae (KP) inner colonies (IC) arising from disk diffusion (DD) in an ascending mouse urinary tract infection (UTI) model
por: Bixby, Morgan, et al.
Publicado: (2023)

1526. Epidemiology of and Risk Factors for Nontyphoidal Salmonella Bacteremia in Children: A 20-Year Retrospective Cohort
por: Greenhow, Tara L
Publicado: (2019)

1526. The economic impact of respiratory syncytial virus (RSV) in infants in the United States: systematic literature review
por: Bowser, Diana, et al.
Publicado: (2020)

Effective Treatment for Uncomplicated Urinary Tract Infections with Oral Fosfomycin, Single Center Four Year Retrospective Study
por: Fajfr, Miroslav, et al.
Publicado: (2020)

Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections?
por: Rodríguez-Gascón, Alicia, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Fosfomycin for Treatment of Uncomplicated Urinary Tract Infections in Ontario
por: Perrault, Louise, et al.
Publicado: (2017)

1367. Clinical Cure in Secondary Efficacy Populations in Patients With Complicated Urinary Tract Infection Treated With ZTI-01 (Fosfomycin for Injection): Findings From the ZEUS Trial
por: Kaye, Keith, et al.
Publicado: (2018)

1526 PrEP implementation in Houston, TX among high-risk heterosexuals and MSM
por: Flash, Charlene A., et al.
Publicado: (2014)

A Comparative Study of Urinary Tests and Cultures for the Effectiveness of Fosfomycin in Catheter-Related Urinary Tract Infections
por: Jo, Jung Ki, et al.
Publicado: (2022)

205. Evaluating the Time to Oral Step-Down Therapy for Gram-Negative Bloodstream Infections Associated with a Genitourinary Source
por: Mulvey, Nicole, et al.
Publicado: (2021)

Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial
por: Gágyor, Ildikó, et al.
Publicado: (2015)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

2412. Our Experience With IV Fosfomycin
por: Savaj, Pratik, et al.
Publicado: (2018)

1386. Efficacy of Repeat Dosing of Oral Fosfomycin in a Dynamic Bladder Infection In Vitro Model
por: Abbott, Iain, et al.
Publicado: (2018)

Real-Life Comparison of Fosfomycin to Nitrofurantoin for the Treatment of Uncomplicated Lower Urinary Tract Infection in Women
por: Shafrir, Asher, et al.
Publicado: (2023)

65. Impact of a Multifaceted Stewardship Intervention on Oral Fosfomycin Prescribing for Treatment of Resistant Organisms in Cystitis
por: Pry, Marie, et al.
Publicado: (2020)

Assessing the Risk of Nephrotoxicity Associated With Non-renally Adjusted Intravenous Polymyxin B Compared with Traditional Dosing
por: Maniara, Bejoy, et al.
Publicado: (2017)

1431. Evaluation of Drug-induced Liver Injury in Patients Receiving Anti-tuberculosis Medications and Subsequent Management
por: Acosta, Carina, et al.
Publicado: (2022)

1568. Evaluating the Appropriateness of Antiretroviral Therapy in the Critical Care Setting
por: Wali, Toobah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_begm9o51tvho13m0lo21inbl27